Discover Portal

Latest important health research summarised

Oops! It looks like the link for that signal has changed. Please search to find what you were looking for and let us know what went wrong by emailing disseminationcentre@nihr.ac.uk or tweeting @NIHR_DC.
Omega 3 Supplement

NIHR Signal Boosting omega-3 fatty acid intake is unlikely to prevent type 2 diabetes

Increasing the intake of polyunsaturated fats in the diet with supplements of omega-3 fatty acids, for example, is unlikely to affect people’s risk of developing type 2 diabetes. However, this review only looked at the effect of supplements on diabetes, not wider health.

This large systematic review included 83 long-term trials comparing... Read More

  • 12 November 2019
  • Signal

Vaccination

NIHR Signal Herpes zoster vaccine reduces chances of shingles after stem cell transplants

A non-live vaccine against herpes zoster provides good, though partial protection for adults undergoing autologous (using the patient’s own) stem cell transplant for treatment of blood cancers. These people cannot use the usual live vaccine, because of their suppressed immune system.

An industry-funded trial of the vaccine involved 1,846... Read More

  • 12 November 2019
  • Signal

NIHR Signal Keyhole hysterectomy is effective for women with heavy menstrual bleeding

When surgical treatment was needed, almost all women with heavy menstrual bleeding were satisfied and had a good quality of life following keyhole surgery to remove the uterus. Slightly fewer achieve this with ablation to remove the uterine lining.

In a UK randomised trial, women given one or other treatment in NHS hospitals reported good... Read More

  • 12 November 2019
  • Signal

Male patient in hospital

NIHR Signal Significant risk of another thrombosis remains if anticoagulation is stopped

Unprovoked venous thromboembolism (VTE), including deep vein thrombosis in the leg and pulmonary embolism, are clots within veins that occur spontaneously in people without risk factors and are treated with anticoagulant drugs. If those drugs are stopped after three months or more, the risk of another clot appears to be on average 10% in the first ... Read More

  • 31 October 2019
  • Signal

Woman coughing

NIHR Signal Long-term macrolide antibiotics reduce risk of exacerbations of bronchiectasis

People with bronchiectasis (not caused by cystic fibrosis) who take long-term macrolide antibiotics are around 50% less likely to experience acute worsening of symptoms like cough and sputum production (an exacerbation) than people taking a placebo.

Bronchiectasis guidelines only recommend preventative macrolide antibiotics in people with... Read More

  • 31 October 2019
  • Signal

Show more articles
Search Portal